MBX Biosciences, Inc. Common Stock

MBXNASDAQHealthcare● Active

$28.86

$-1.42(-4.69%)

Market Cap$969497703

P/E Ratio—

52W High$45.85

52W Low$9.43

Avg Volume569K

Open$30.63

Beta0.75

Overview

MBX Biosciences, Inc. Common Stock（MBX）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · MBX · 截至 2026年6月8日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

1.00

Buy/Sell (by trades)

整体情绪

中性

↑ Buy 50%仅显示有效交易 · 排除RSU归属50% Sell ↓

MBX Biosciences, Inc. Common Stock内部人在过去近12个月买卖活动混合。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月8日

MBX 季度内部人买卖趋势

MBX 内幕交易卖出 · MBX 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

667K333K0

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 8, 2026

活跃内部人

近12个月交易最活跃 · MBX CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

MBX 高管卖出股份 · MBX 董事内幕交易 · SEC Form 4申报

显示最近 17 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
May 8, 2026	Azoulay Salomon Chief Medical Officer	Option	55,000	$10.46	$575K	69,769	Form 4
May 8, 2026	Azoulay Salomon Chief Medical Officer	Option	15,003	$16.00	$240K	29,772	Form 4
May 8, 2026	Azoulay Salomon Chief Medical Officer	Sale	15,003	$38.30	$575K	14,769	Form 4
May 8, 2026	Azoulay Salomon Chief Medical Officer	Sale	55,000	$38.38	$2.11M⚡	14,769	Form 4
May 6, 2026	Azoulay Salomon Chief Medical Officer	Sale	231	$29.54	$7K	14,769	Form 4
May 6, 2026	Hawryluk P. Kent President & CEO · Director	Sale	607	$29.54	$18K	727,667	Form 4
May 1, 2026	Hoerter Steven L. Director	Award	11,938	—	—	11,938	Form 4
Mar 13, 2026	Hawryluk P. Kent President & CEO · Director	Purchase	18,500	$28.41	$526K	486,777	Form 4
Feb 26, 2026	Hawryluk P. Kent President & CEO · Director	Option	28,768	$16.00	$460K	728,274	Form 4
Feb 2, 2026	Azoulay Salomon Chief Medical Officer	Award	15,000	—	—	15,000	Form 4
Feb 2, 2026	Bartram Richard CFO	Award	15,000	—	—	15,000	Form 4
Feb 2, 2026	Hawryluk P. Kent President & CEO · Director	Award	35,250	—	—	699,506	Form 4
Oct 24, 2025	Hawryluk P. Kent President & CEO · Director	Option	182,859	$3.25	$594K	664,256	Form 4
Oct 20, 2025	Hawryluk P. Kent President & CEO · Director	Purchase	20,000	$13.64	$273K	468,277	Form 4
Oct 17, 2025	Hoerter Steven L. Director	Purchase	20,000	$13.25	$265K	20,000	Form 4
Sep 26, 2025	Heron Patrick J Director	Purchase	666,666	$18.00	$12.00M⚡	5,219,440	Form 4
Apr 8, 2025	Pescovitz Ora H. Director	Purchase	7,693	$5.89	$45K	24,329	Form 4

Azoulay Salomon

Chief Medical Officer

Option

日期

May 8

股数

55,000

均价

$10.46

总金额

$575K

View Form 4 on SEC.gov

Azoulay Salomon

Chief Medical Officer

Option

日期

May 8

股数

15,003

均价

$16.00

总金额

$240K

View Form 4 on SEC.gov

Azoulay Salomon

Chief Medical Officer

Sale

日期

May 8

股数

15,003

均价

$38.30

总金额

$575K

View Form 4 on SEC.gov

Azoulay Salomon

Chief Medical Officer

Sale

日期

May 8

股数

55,000

均价

$38.38

总金额

$2.11M ⚡

View Form 4 on SEC.gov

Azoulay Salomon

Chief Medical Officer

Sale

日期

May 6

股数

231

均价

$29.54

总金额

$7K

View Form 4 on SEC.gov

Hawryluk P. Kent

President & CEO · Director

Sale

日期

May 6

股数

607

均价

$29.54

总金额

$18K

View Form 4 on SEC.gov

Hoerter Steven L.

Director

Award

日期

May 1

股数

11,938

均价

—

总金额

—

View Form 4 on SEC.gov

Hawryluk P. Kent

President & CEO · Director

Purchase

日期

Mar 13

股数

18,500

均价

$28.41

总金额

$526K

View Form 4 on SEC.gov

Hawryluk P. Kent

President & CEO · Director

Option

日期

Feb 26

股数

28,768

均价

$16.00

总金额

$460K

View Form 4 on SEC.gov

Azoulay Salomon

Chief Medical Officer

Award

日期

Feb 2

股数

15,000

均价

—

总金额

—

View Form 4 on SEC.gov

Bartram Richard

CFO

Award

日期

Feb 2

股数

15,000

均价

—

总金额

—

View Form 4 on SEC.gov

Hawryluk P. Kent

President & CEO · Director

Award

日期

Feb 2

股数

35,250

均价

—

总金额

—

View Form 4 on SEC.gov

Hawryluk P. Kent

President & CEO · Director

Option

日期

Oct 24

股数

182,859

均价

$3.25

总金额

$594K

View Form 4 on SEC.gov

Hawryluk P. Kent

President & CEO · Director

Purchase

日期

Oct 20

股数

20,000

均价

$13.64

总金额

$273K

View Form 4 on SEC.gov

Hoerter Steven L.

Director

Purchase

日期

Oct 17

股数

20,000

均价

$13.25

总金额

$265K

View Form 4 on SEC.gov

Heron Patrick J

Director

Purchase

日期

Sep 26

股数

666,666

均价

$18.00

总金额

$12.00M ⚡

View Form 4 on SEC.gov

Pescovitz Ora H.

Director

Purchase

日期

Apr 8

股数

7,693

均价

$5.89

总金额

$45K

View Form 4 on SEC.gov

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 MBX 内幕交易

MBX 内幕交易

MBX Biosciences, Inc. Common Stock（MBX）内幕交易数据来源于公司内部人（包括Azoulay Salomon (Chief Medical Officer), Hawryluk P. Kent (President & CEO · Director), Hoerter Steven L. (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。MBX内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看MBX Biosciences, Inc. Common Stock机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

MBX 内幕交易 · 5个问题

MBX Biosciences, Inc. Common Stock（MBX）的内部人包括高管和董事，如Azoulay Salomon (Chief Medical Officer), Hawryluk P. Kent (President & CEO · Director), Hoerter Steven L. (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

MBX 董事内幕交易MBX 内部人名单MBX Biosciences, Inc. Common Stock 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026